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Autopsy Specimens With a Novel Catheter-
Based Near-Infrared Spectroscopy System
Craig M. Gardner, PHD,* Huwei Tan, PHD,* Edward L. Hull, PHD,*
Jennifer B. Lisauskas, MS,* Stephen T. Sum, PHD,* Thomas M. Meese, BS,*
Chunsheng Jiang, PHD,* Sean P. Madden, PHD,* Jay D. Caplan, BS, MBA,*
Allen P. Burke, MD,† Renu Virmani, MD,‡ James Goldstein, MD,§ James E. Muller, MD*
Burlington, Massachusetts; Washington, DC; Gaithersburg, Maryland; and Royal Oak, Michigan
O B J E C T I V E S This study sought to assess agreement between an intravascular near-infrared
spectroscopy (NIRS) system and histology in coronary autopsy specimens.
B A C KG ROUND Lipid core plaques cannot be detected by conventional tests, yet are suspected to be
the cause of most acute coronary syndromes. Near-infrared spectroscopy is widely used to determine the
chemical content of substances. A NIRS system has been developed and used successfully in 99 patients.
METHOD S Scanning NIRS was performed through blood in 212 coronary segments from 84
autopsy hearts. One histologic section was analyzed for every 2 mm of artery. Lipid core plaque of
interest (LCP) was deﬁned as a lipid core 60° in circumferential extent, 200-m thick, with a mean
ﬁbrous cap thickness 450 m. The ﬁrst 33 hearts were used to develop the algorithm; the subsequent
51 validation hearts were used in a prospective, double-blind manner to evaluate the accuracy of NIRS
in detecting LCP. A NIRS-derived lipid core burden index for an entire artery was also validated by
comparison to histologic ﬁndings.
R E S U L T S The LCPs were present in 115 of 2,649 (4.3%) sections from the 51 validation hearts. The
algorithm prospectively identiﬁed LCP with a receiver-operator characteristic area of 0.80 (95% conﬁdence
interval [CI]: 0.76 to 0.85). The lipid core burden index detected the presence or absence of any ﬁbroatheroma
with an area under the curve of 0.86 (95% CI: 0.81 to 0.91). A retrospective analysis of lipid core burden index
conducted in extreme artery segments with either no or extensive ﬁbroatheroma yielded an area under the
curve of 0.96 (95% CI: 0.92 to 1.00), conﬁrming the accuracy of spectroscopy in identifying plaques with
markedly different lipid content under ideal circumstances.
CONC L U S I O N S This novel catheter-based NIRS system accurately identiﬁed lipid core plaques
through blood in a prospective study in coronary autopsy specimens. It is expected that this novel
capability will be of assistance in the management of patients with coronary artery disease. (J Am Coll
Cardiol Img 2008;1:638–48) © 2008 by the American College of Cardiology Foundation
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employees at the time of this study. Dr. Goldstein is an InfraReDx consultant and equity owner. Drs. Burke and Virmani were
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639xtensive evidence suggests that coronary ar-
tery plaques with a lipid core are the cause of
most acute coronary events (1,2). Unfortu-
nately, current diagnostic techniques, includ-
ng invasive coronary angiography, cannot identify
hese presumably high-risk structures. Although
ear-infrared spectroscopy (NIRS) is widely used in
any disciplines to identify the chemical composi-
ion of unknown substances, including lipids, it has
ot been possible to use this powerful analytic
echnique to examine the composition of coronary
laques in living patients.
See page 649
Over the past decade, studies conducted by multiple
roups have documented that NIRS can accurately
dentify lipid-rich atherosclerotic plaques in autopsy
pecimens under laboratory conditions (3). None of
hese ex vivo studies has addressed the full range of
ifficulties that would be encountered in examination
f coronary plaques in patients. To perform spectro-
copic assessment of coronary plaques, the NIRS
evice would need to access the artery, use wave-
engths that can penetrate blood, scan the length and
ircumference of the artery, and obtain measurements
t sufficient speed to overcome interference due to
ardiac motion. A catheter-based spectroscopy system
hat fulfills these 4 criteria has been developed and
sed successfully to obtain NIRS measurements in 99
atients (4).
The purpose of the present study was to test the
bility of this NIRS system to detect lipid core
laques in human coronary artery autopsy speci-
ens in which the gold standard of histology is
vailable. The system consists of a near-infrared
aser, an optical catheter similar in size and use to an
ntravascular ultrasound catheter, a pullback and
otation device, and an analytic algorithm to calcu-
ate the probability that a lipid core plaque is
resent at each location examined. The algorithm
as developed with the use of a calibration set of 86
uman coronary artery segments from 33 hearts and
hen tested in a prospective study of 126 coronary
egments from 51 hearts. The NIRS measurements
ere obtained under pressure, temperature, and
lood flow conditions simulating those encountered
n patients undergoing catheterization.
E T H O D S
he NIRS calibration and validation measurements
ere obtained over 2 years in specimens from 84 Auman hearts. The last 51 hearts were used in the
alidation study with a finalized NIRS algorithm and
rospectively defined end points. The analysis was
ouble-blinded: those constructing the algorithm in
he calibration phase did not have access to histologic
ata from the validation phase, and those performing
he NIRS and histologic analyses during the valida-
ion phase did not have access to the algorithm.
pecimens. Hearts were acquired from the National
isease Research Interchange or the International
nstitute for the Advancement of Medicine per a
rotocol approved by an institutional review board.
earts were received within 48 h after death, main-
ained on ice at 4°C and measured within 96 h after
eath. The major coronary arteries were examined in
itu using angioscopy to exclude severely stenotic or
ccluded segments impassable (1 mm diameter) by
he NIRS catheter.
Following angioscopic screening, arterial seg-
ents with epivascular tissue were harvested for
easurement. Side branches were ligated
o prevent loss of blood during perfusion.
ach arterial segment was then mounted
n a custom fixture (Fig. 1A) and both
nds of the segment were attached to luer
onnectors that allowed fluid flow and
atheter entry.
IRS. The 3.2-F InfraReDx (Burlington,
assachusetts) NIRS catheter (Fig. 1D)
as advanced along a 0.014-inch guide-
ire through the segment mounted in the
xture. The segment was perfused with
uman blood at body temperature. A vari-
taltic pump (Manostat, Barnant Corp., Bar-
ington, Illinios) supplied pulsatile blood flow at 60
ycles/min, providing a flow rate of approximately
30 ml/min. Outflow pressure was maintained at 80
o 120 mm Hg. Spectral data were collected inside
he segment during automated NIRS catheter pull-
ack at 0.5 mm/s and 240 rpm.
istopathology. After the NIRS measurements
ere obtained, the segments were pressure-fixed in
ormalin and decalcified with EDTA. Each seg-
ent was then cut perpendicular to the longitudinal
xis of the vessel at 2-mm intervals of the fixture’s
uideposts (Fig. 1B). Two 5-m histopathology
lides were prepared at the CVPath Institute from
he distal side of each 2-mm block and stained with
ematoxylin-eosin and Russell-Movat’s penta-
hrome, respectively. Histologic features of the
rteries were classified by a CVPath pathologist
A.P.B.) according to a modified American Heart
A B B
A N D
AUC
IVUS
LCBI
LCP
intere
NIRS
spectr
ROC
charassociation classification scheme (5).R E V I A T I O N S
A C R O N YM S
area under the curve
 intravascular ultrasound
lipid core burden index
lipid core plaque of
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 near-infrared
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640Each histopathology slide was digitized using a
tandard microscope at 1.25 magnification. Using
ustom software, contours were drawn on each
mage to identify fiducial markers retained by the
issue-preparation inking scheme, the lumen
oundary, lipid pools at sites of pathological intimal
hickening, and noncalcified and calcified lipid
ores in fibroatheroma (Fig. 1C).
To provide a quantitative target suitable for
lgorithm construction and validation, a lipid core
laque of interest (LCP) was defined as fibroathe-
oma with lipid core60° in circumferential extent,
200 m thick, with a fibrous cap having a mean
hickness 450 m. Using this definition, each
lock that was of adequate quality for histologic
lassification and histomorphometry was classified
s either positive or negative for presence of LCP.
lso, the normalized lipid core volume was defined
s the total lipid core volume identified by histo-
orphometry in a segment divided by the segment
ength and was used to assess accuracy of NIRS at
he segment level.
orrelation between NIRS and histopathology. Both
lgorithm calibration and validation require longi-
Figure 1. Apparatus for Fixing an Arterial Sample, Gross and Hi
(A) A coronary artery segment mounted in a ﬁxture to ensure regis
histology. The vertical rods permit precise sectioning at 2-mm inter
etry outlines show the lumen (red), lipid core (blue), and a small lip
green. Radii used to measure cap and core thickness are in black. (udinal coregistration of NIRS data with the his- iology truth standard. To accomplish this, the
ullback location of the distal metal luer’s inner
dge was identified in a NIRS pullback, labeled as
he 0-mm pullback position, and associated with
he distal-most histology thin section.
The outputs of the NIRS algorithm for each
ullback, which will be described in Figure 3, are a
hemogram image, a block chemogram, and a lipid
ore burden index (LCBI). The ability of NIRS to
etect localized LCP in 2-mm blocks was evaluated
sing receiver-operator characteristic (ROC) anal-
sis of the NIRS block chemogram intensity values
ersus the LCP truth values from histology for all
-mm blocks with lumen diameters 3 mm. The
bility of NIRS to detect the presence of any-sized
broatheroma in an artery segment was evaluated
sing ROC analysis of the LCBI values versus histol-
gy truth (presence or absence of fibroatheroma).
tatistics. The study was powered to test the null
ypothesis that the area under the curve (AUC) for
etecting LCP in lumens 3 mm in diameter
ould be 0.72. The required sample size was
stimated for 80% power and 95% confidence
ogic Views, and Close-Up of NIRS Catheter
on of intraluminal near-infrared spectroscopy (NIRS) signals with
. (B and C) Gross and microscopic cross-sections. Histomorphom-
ool (yellow). The angle subtended by the lipid core is shown in
he imaging tip of the NIRS catheter lying on a U.S. penny.stol
trati
vals
id pnterval (CI) (2-sided) using the power calculations
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641ppropriate for AUC testing (6) using PASS sta-
istical software (NCSS, Kaysville, Utah).
Statistical analyses were performed using MAT-
AB (The MathWorks, Inc., Natick, Massachu-
etts). Confidence intervals were 2-sided 95% levels
nd were calculated using a bootstrap method that
ccounts for the possibility of any within-segment
nd within-heart correlations (7). All donor and
CP characteristics were not normally distributed
nd therefore are reported as median with inter-
uartile range for non-normal data.
E S U L T S
onor and tissue characteristics. Table 1 shows the
haracteristics for the 51 validation hearts. The
erfusate blood lipid chemistry covered a wide
ange of profiles and was not correlated with he-
atocrit (data not shown). Histopathologic exam-
nation of each 2-mm segment identified 115 LCP
4.3%) in 30 of 51 donors (59%), the characteristics
f which are presented in Table 2.
ield of adequate data. A total of 2,496 blocks
rom 126 segments and 51 hearts were histolog-
cally and spectrally adequate for the validation
hase (Fig. 2). In addition to block adequacy,
nalysis of the LCBI required assessment of each
Table 1. Clinical Characteristics of Heart Donors in Validation
Data Set at Time of Death
Characteristic Value
Number 51
Demographic proﬁle
Male, n (%) 36 (71)
Age in yrs, median (interquartile range) 68 (53–81)
Medical history, n (%)
Hypertension 31 (61)
Chronic smoker 21 (41)
Diabetes mellitus 17 (33)
Prior presentation CHF 16 (31)
Prior MI 11 (22)
Prior CABG 4 (8)
Cause of death, n (%)
Cardiovascular related 40 (78)
Cerebrovascular accident 15 (29)
Cardiac arrest 13 (25)
MI 7 (14)
Cardiopulmonary arrest 3 (6)
Other cardiac cause 2 (4)
Noncardiovascular related 8 (16)
Unknown 3 (6)
Complete characteristics were not available for all donors.
CABG  coronary artery bypass graft; CHF  congestive heart failure; MI 0myocardial infarction.egment’s data adequacy. Five segments were
xcluded because 25% of the chemogram pixels
ere spectrally inadequate, and 1 was excluded
ecause 8 of its 26 blocks were not processed or
ere histologically inadequate.
alidation. Outputs of the NIRS algorithm (che-
ogram and block chemogram) for a segment
ontaining LCP and for a normal segment are
hown in Figures 3 and 4. The primary analysis was
onducted by comparing the block chemogram
eadings with histologic classifications using all
,909 adequate 2-mm blocks with lumen diameters
3 mm. The ROC analysis resulted in an AUC of
.80 (95% CI: 0.76 to 0.85) (Fig. 5). Exploratory
nalyses that assess the accuracy of extreme cases for
hich there are fewer sources of false-positives and
alse-negatives are also presented in Figure 5. The
UCs in these exploratory analyses were 0.89 (95%
I: 0.85 to 0.94) and 0.87 (95% CI: 0.77 to 0.97).
ources of false-positive and false-negative readings
re shown in Figure 6.
The LCBI values for 120 segments from 51
earts were exponentially distributed (range: 0 to
22) and are plotted against categorized normal-
zed lipid core volume in Figure 7. The ROC
urve for NIRS detecting an artery with lipid core
s shown in Figure 8 and resulted in an AUC of
.86 (95% CI: 0.81 to 0.91). Also shown in the
gure is an ROC curve for an exploratory analysis
or detecting clinically high lipid core burden
sing the LCBI, which resulted in an AUC of
Table 2. Characteristics of LCPs in Validation Data Set
Characteristic Value
n (%) 115 (4.3)
Number per heart, n (interquartile range) 1 (0–4)
Number contained in artery, n (%)
Left anterior descending 47 (41)
Left circumﬂex 25 (22)
Right 43 (37)
Distance from ostium (mm)
Left anterior descending 32 (23–42)
Left circumﬂex 18 (12–39)
Right 60 (27–84)
Lumen diameter (mm) 2.4 (2.0–2.9)
Number with calciﬁed core, n (%) 45 (39)
Cross-sectional area (mm2) 1.2 (0.8–2.1)
Minimum cap thickness (m) 164 (101–243)
Core thickness (m) 448 (315–565)
Plaque angle (°) 102 (77–132)
All continuous variables reported as median (interquartile range).
LCP  lipid core plaque of interest..96 (95% CI: 0.92 to 1.00).
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642138 segments from
51 hearts prepared
174 blocks excluded by NIRS algorithm
due to extreme spectral shapes
2649 blocks
histologically adequate
2804 blocks
spectrally adequate
126 segments from
51 hearts scanned
(2978 blocks)
2496 blocks from
126 segments histologically
and spectrally adequate
12 segments excluded
 3: stent prevented histology
 4: unable to advance catheter
 2: no blood flow
 3: procedural set-up error329 blocks excluded by histology
 264: unable to cut block from segment
 37: thin section not intact
 18: quality review incomplete
 10: unresolved disagreement
       between histology and 
       morphometry
Figure 2. Flow Chart of Inclusion Criteria
Flow diagram describing the selection of data that met prospectively speciﬁed histologic and spectral criteria for inclusion in the blinded
validation. NIRS  near-infrared spectroscopy.Figure 3. A NIRS Scan Correlates Well to Histologic Findings in Coronary Artery From an 85-Year-Old Male With a History of MI
(A) Chemogram image indicating artery wall lipid content (x axis  pullback in millimeters; y axis  rotation in degrees). Each pixel is
marked with red for low probability and yellow for high probability of lipid core plaque of interest (LCP). The lipid core burden index
(top right) indicates amount of lipid in scanned artery on a 0 to 1,000 scale. (B) Summary (block chemogram) of LCP presence at 2-mm
intervals in 4 probability categories. (C) Map of histologic classiﬁcations (yellow  LCP; light orange  small or thick-capped ﬁbroathe-
roma; dark orange  intimal xanthoma and pathologic intimal thickening; red  all other types). (D) Movat cross-sections from loca-
tions along the artery (dotted lines). Black bars denote 1 mm. Image interpretation: The chemogram shows prominent lipid core signal
at 2 to 16 mm, occupying 180°. The block chemogram shows that the strongest LCP signals extend 5 to 11 mm. The NIRS signals at 18
and 42 mm correctly indicate absence of LCP. MI  myocardial infarction; other abbreviations as in Figure 1.
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643I S C U S S I O N
his study demonstrates that this novel catheter-
ased NIRS system can identify lipid core plaques
hrough blood in human coronary artery autopsy
pecimens as validated by histology. The AUC
Figure 4. A Chemogram From a 45-Year-Old Female Who Died
The NIRS reading of no LCP is conﬁrmed by histology. Abbreviation
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AUC=0.803 (0.760-0.849 CI)
Figure 5. ROC Curves Showing Agreement Between NIRS Signal
(A) Prespeciﬁed end point analysis to discriminate 2-mm blocks con
with lumen diameters 3 mm. (B) Exploratory analyses conducted
blocks containing noncalciﬁed LCPs versus blocks without lipid. (B2
that span 3 or more consecutive 2-mm blocks from all other tissue
teristic; other abbreviations as in Figures 1 and 3.alues obtained for detection of localized LCPs and
f any fibroatheroma were 0.80 and 0.86, respec-
ively. These values are representative of the perfor-
ance of commonly used intravascular and other
iagnostic modalities (8–10).
noxia
in Figures 1 and 3.
False Positive Rate
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B1: AUC=0.892 (0.847-0.938 CI)
B2: AUC=0.867 (0.778-0.967 CI)
s Indicated by Block Chemogram) and Histology
ing LCP from blocks containing all other tissue types in blocks
locks with lumen diameters 2.5 mm. (B1) Discrimination of
scrimination of LCPs identiﬁed by requiring block chemograms
s. AUC  area under the curve; ROC  receiver-operator charac-of As (a
tain
in b
) Di
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logic intimal thickening; -pool  spatially localized lipid pools; TCFA t
malized lipid core volume per artery segment based on histologic ﬁndings.
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644Using a threshold separating the 2 middle colors
n the block chemograms of Figures 3 and 4, the
ensitivity, specificity, positive predictive value, and
egative predictive value were 49%, 90%, 19%, and
7%, respectively, in detecting localized LCP. The
ow positive predictive value was expected due to its
trong dependence on disease prevalence, which
as 4% in this study. The prevalence of LCP in
uptured plaques is approximately 70% (1), which
ould result in positive and negative predictive
alues of 92% and 43%, respectively, if the same
ensitivity and specificity were achieved in the
ubset of artery wall-containing ruptured plaques.
The present study is similar to ex vivo validation
tudies of other intracoronary imaging devices (11–
4) in that we measured fresh coronary artery tissue
t body temperature from multiple donors and
ompared it with the histology. Our study differs in
hat we perfused the arteries with blood rather than
aline. Our study also had a lower prevalence of
ipid core plaque (4% vs. 17% to 48%) because we
-pool FA-CC FA LCP (+)
Late FA Late FA-CC TCFA
LCP (+)
(boxes) of block chemogram readings for different histologic clas-
s. Higher y-axis values for LCP-negative result in false-positive
ned as LCP (FA) were the major source of false-positive readings.
xis values for LCP-positive result in false-negative readings. The
ource of false-negative readings. AIT  adaptive intimal thicken-
lciﬁed nodule; -diff  spatially diffuse lipid; FA  ﬁbroatheroma
re; IX  intimal xanthoma; NML  normal tissue; PIT  patho-
hin-capped ﬁbroatheroma; other abbreviations as in Figure 3.NML, AIT, BF CF, CN IX, PIT-diff PIT
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Figure 6. Sources of False Positive and False Negative
The graph displays medians (horizontal lines) and interquartile ranges
siﬁcations. (A) The LCP-negative class expanded into histologic subtype
readings. Fibroatheroma that were too small or thick-capped to be deﬁ
(B) The LCP-positive class expanded into histologic subtypes. Lower y-a
LCPs with calciﬁed cores (Early FA-CC and Late FA-CC) were the main s
ing; BF  bland ﬁbrous plaque; CF  calciﬁed ﬁbrous plaque; CN  ca
without calciﬁed core; FA-CC  ﬁbroatheroma with calciﬁed necrotic coLi
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645iseased. The analysis of all tissue types through
owing blood yields accuracy calculations that are
linically relevant.
The clinical importance of this autopsy validation
s enhanced by the successful use of this catheter in
9 patients with demographic characteristics similar
o those of this autopsy study and the recent
learance of the device by the Food and Drug
dministration for commercial sales in the U.S.
he cost of the catheter will be equivalent to the
ost of a drug-eluting stent, and the cost of the
onsole will be equivalent to that of an intravascular
ltrasound (IVUS) console.
xploratory analyses. Exploratory analyses revealed
hat a major cause of false positives was the
ccurrence of a NIRS-positive signal over a lipid
ore that was too small or covered by a cap too
hick to meet criteria for a LCP. Lesions with
ignificant lipid but without lipid cores (intimal
anthoma and pathologic intimal thickening) also
ometimes resulted in false-positive readings.
uch false positives are less a failure of spectros-
opy (i.e., lipid was present and generated a
IRS signal) than a sign of the difficulty pro-
uced by categorizing various sizes of lipid core
laques and types of lipid accumulation into a
inary histology-based classification scheme.
False-negative readings were most frequently
roduced by lipid cores with extensive calcifica-
ion, a finding consistent with the presence of
ewer lipids in such cores due to displacement of
ipid by calcium. The ability of near-infrared
False Positive Rate
Se
ns
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ty
0.8
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0
AUC=0.859 (0.807-0.910 CI)
Figure 8. ROC Analysis of Agreement Between LCBI and Histolo
(A) Prospective end point evaluated in all scanned artery segments
NIRS LCBI. (B) Retrospective analysis conducted in extreme scanned
millimeter of artery length. Abbreviations as in Figures 1, 5, and 7.ight to penetrate through calcium makes it lnlikely that near-infrared signals will be affected
y “shadowing” artifacts as markedly as are ultra-
ound examinations.
To test the ability of the NIRS system to
iscriminate clearly differentiated histologic ref-
rence classes, an analysis was performed com-
aring extremes (LCP with noncalcified lipid
ores versus regions without lipid). The AUC of
.89 (95% CI: 0.85 to 0.94) supports the excel-
ent ability of NIRS to discriminate tissue types
ased on chemical composition; it is not a mea-
ure of the performance obtainable in vivo be-
ause the cardiologist cannot eliminate the inter-
ediate histologic areas from a scanned artery
sing only NIRS and angiography.
The primary end point compares block chemo-
ram intensity readings with the histologic standard
n isolated 2-mm blocks and does not use informa-
ion from adjacent blocks to enhance accuracy. The
ccuracy of an interpretation comparing positivity
y NIRS in 3 or more adjacent blocks versus blocks
ith no LCP was 0.87 (95% CI: 0.77 to 0.97). This
nalysis indicates that the appearance of a long and
road yellow signal in the chemogram is an excel-
ent indicator of the presence of a LCP.
Because lipid core plaque intensities generally
ncrease with the size and concentration of focal
holesterol deposits and with the extent of inti-
al connective tissue degradation, this NIRS
evice can be characterized as a lipid core plaque
etector that is most sensitive to cholesterol-rich
egions containing tissue necrosis. Besides a large
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646haracteristic of plaque vulnerable to rupture
15,16). Although the algorithm was not de-
igned to identify the chemical signature of in-
ammation, there is a close correlation between
ipid cores and inflammation (17). This correla-
ion has resulted in successful identification of
nflammation indirectly by NIRS (18). NIRS also
rovides an indirect index of cap thickness be-
ause the lipid core signal is attenuated exponen-
ially by the thickness of the cap. However, in the
linical setting, this relationship between signal
trength and cap thickness is confounded by
ariations in both core size and intervening blood
ayer thickness. Investigational devices that em-
loy optical coherence tomography (11) or optical
requency domain imaging (19) provide the most
ccurate method to measure cap thickness in the
bsence of intervening blood.
tudy limitations. The current study did not use
iving tissue. However, because the specimens were
aintained on ice and studied soon after death, the
arget of the imaging (i.e., bulk lipid-rich chemical
ignatures that are not dependent on living cells) is
ot likely to differ significantly from the target in
iving tissue.
Coronary motion was not simulated. However,
he high speed of data acquisition (5 ms/spectrum,
0 spectra/s) guarantees that high-quality spectra
an be obtained despite cardiac movement.
Finally, the tortuous anatomy of the coronary
asculature was avoided to enhance coregistration of
he entire scanned coronary segment with histology.
eparate bench testing of the catheter’s perfor-
ance in a tortuous path has verified that the
atheter is safe and tracks well in a simulated
oronary anatomy.
All 3 of these limitations are due to differences
etween this ex vivo validation and the clinical
pplication of the device. Ex vivo validation versus
istopathology is recommended by the Food and
rug Administration for diagnostic coronary cath-
ters that measure plaque characteristics (20). To
xperimentally address the limitations of ex vivo
alidation, the SPECTACL (SPECTroscopic As-
essment of Coronary Lipid) clinical study was
esigned with a primary end point of spectral
imilarity between in vivo and ex vivo pullbacks, and
he end point was achieved (21).
otential clinical utility of the NIRS system. This suc-
essful autopsy validation, together with the clinical
esults (21) and Food and Drug Administration’s
10(k) clearance, indicates that a new, easily used
ool to identify lipid core plaques is now available. iipid core plaque identification will supplement the
nformation about stenosis obtained over the past
0 years with the use of coronary angiography and
ill open many possibilities for improved risk strat-
fication and treatment that can be tested in formal
tudies.
For risk stratification, NIRS will facilitate pro-
pective studies testing the hypothesis that the
resence of lipid core plaque identifies individual
laques and/or patients at higher risk of a subse-
uent coronary event. These trials will assist cardi-
logists in identifying the proper use of this novel
echnology.
For treatment, knowledge of the presence of lipid
ore plaques in an artery is likely to be useful in
electing among the 3 major treatments for coro-
ary artery disease—medical therapy, stenting, and
ypass surgery—and as a means of improving out-
omes within each of the 3 categories.
With regard to medical therapy, identification of
xtensive lipid core plaque might indicate the need
or more aggressive low-density lipoprotein lower-
ng, high-density lipoprotein raising, and anti-
hrombotic therapy.
For stenting therapy, lipid core plaque identifi-
ation might assist the interventionalist in selecting
he optimal length of artery to stent. At present the
ength to be stented is chosen on the basis of
tenosis length as assessed by angiography or IVUS
nd does not take into account the length of
ssociated lipid core plaque. NIRS may also be
elpful for selecting a drug-eluting or bare-metal
tent because the endothelium does not grow over
rug-eluting stents as well as bare metal stents
hen located over a lipid core plaque (22).
NIRS has the potential to contribute to resolu-
ion of the controversy concerning selection of
tenting or medical therapy in patients with stable
ngina. As reported by Boden et al. (23), a strategy
f initial medical care or initial stenting produced
imilar long-term outcomes for treatment of lesions
ssessed only on the basis of stenosis. A subsequent
rial could be conducted to determine if lipid core
esions respond differently than fibrotic lesions to
edical or stenting therapy.
NIRS may also move interventional cardiology
loser to toward its goal of prevention of second
oronary events from nonstenotic lesions that are
beneath the angiographic radar screen” (24) and
ould not currently receive local treatment. These
esions are more likely to occur in patients with an
cute coronary syndrome in which multiple plaque
nstability has been documented (25–27).
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647The combination of NIRS findings with other
ntravascular measurements should improve diag-
ostic information. For example, Fukumoto et al.
28) have shown that localized elevation of shear
tress, which can be derived from IVUS and flow
easurements, is associated with sites of plaque
upture. It is possible that the occurrence of in-
reased shear stress over a LCP increases the risk of
upture and a clinical event. This would explain the
ell-documented triggering of infarction by heavy
xertion, and the association between hemody-
amic stress and plaque vulnerability (29,30).
NIRS may also be useful for development of
ovel antiatherosclerotic drugs as a means to mea-
ure changes in composition of a plaque with
herapy and to identify very-high risk patients for
tudies with clinical outcomes.
O N C L U S I O N S
 catheter-based NIRS system now available for8. Chamuleau SAJ, Meuwissen M, van
Eck-Smit BLF, et al. Fractional flow 2002;106:2200–6.ary autopsy specimens and a clinical trial. This
evice permits identification of lipid core coronary
laques in patients, thereby supplementing the
tructural information provided by the coronary
ngiogram and IVUS. It is expected that this novel
apability will lead to multiple studies designed to
mprove both risk stratification and treatment of
atients with coronary artery disease.
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